APPLICATION SITE BURNING

APPLICATION SITE BURNING was reported 105 times

These drug classes are most commonly taken by patients reporting APPLICATION SITE BURNING:

# Drug Count
0 Cholinergic Nicotinic Agonist [EPC] 5
1 Nonsteroidal Anti-inflammatory Drug [EPC] 5
2 Estrogen [EPC] 4
3 Cardiac Glycoside [EPC] 3
4 Central alpha-2 Adrenergic Agonist [EPC] 3
5 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
6 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
7 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
8 Nicotinic Acid [EPC] 3
9 Non-Standardized Food Allergenic Extract [EPC] 3
10 Platelet Aggregation Inhibitor [EPC] 3
11 Thiazide Diuretic [EPC] 3
12 Vitamin B12 [EPC] 3
13 Vitamin C [EPC] 3
14 Vitamin D [EPC] 3
15 Antidote [EPC] 2
16 Antidote for Acetaminophen Overdose [EPC] 2
17 Benzodiazepine [EPC] 2
18 Folate Analog [EPC] 2
19 HMG-CoA Reductase Inhibitor [EPC] 2
20 Loop Diuretic [EPC] 2
21 Mucolytic [EPC] 2
22 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
23 Standardized Chemical Allergen [EPC] 2
24 Vitamin A [EPC] 2
25 beta-Adrenergic Blocker [EPC] 2
26 5-alpha Reductase Inhibitor [EPC] 1
27 Aminoglycoside Antibacterial [EPC] 1
28 Aminosalicylate [EPC] 1
29 Angiotensin 2 Receptor Blocker [EPC] 1
30 Anthelmintic [EPC] 1
31 Antiseptic [EPC] 1
32 Azole Antifungal [EPC] 1
33 Bile Acid Sequestrant [EPC] 1
34 Calcium [EPC] 1
35 Corticosteroid [EPC] 1
36 Dietary Cholesterol Absorption Inhibitor [EPC] 1
37 Insulin Analog [EPC] 1
38 Leukocyte Growth Factor [EPC] 1
39 Macrolide Antimicrobial [EPC] 1
40 Mood Stabilizer [EPC] 1
41 Muscle Relaxant [EPC] 1
42 Nitrate Vasodilator [EPC] 1
43 Opioid Agonist [EPC] 1
44 Oxazolidinone Antibacterial [EPC] 1
45 Progestin [EPC] 1
46 Prostaglandin Analog [EPC] 1
47 Proton Pump Inhibitor [EPC] 1
48 Tetracycline-class Drug [EPC] 1
49 alpha-Hydroxy Acid [EPC] 1
50 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1